Who is sponsoring NCT05911867?

NCT05911867 is sponsored by Cairo University.

What drugs are being tested in NCT05911867?

Interventions in NCT05911867: combination of mobilization with movement and muscle energy techniques, muscle energy techniques Interventions:, mobilization with movement.

What condition does NCT05911867 study?

NCT05911867 studies Mobility Limitation, Muscle Relaxation, Kinematics, Postural; Defect, Breast Cancer.

Is NCT05911867 still recruiting?

NCT05911867 is currently status unknown. Last updated 22 June 2023.

Last reviewed 2023-06-22 · How we verify

NCT05911867: MWMMET

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Muscle Energy Technique and Mulligan's Mobilization in Breast Cancer Surgery Patients

Status unknown NA Last updated 22 June 2023

What this trial tests

NA trial testing combination of mobilization with movement and muscle energy techniques in Mobility Limitation in 108 participants. Status unknown.

Timeline

1 June 2023

Primary endpoint
15 September 2023

30 September 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	108
Start date	1 June 2023
Primary completion	15 September 2023
Estimated completion	30 September 2023
Sites	1 location across Egypt

Drugs / interventions tested

combination of mobilization with movement and muscle energy techniques
muscle energy techniques Interventions:
mobilization with movement — full drug profile →

Conditions studied

Mobility Limitation — all drugs for Mobility Limitation →
Muscle Relaxation — all drugs for Muscle Relaxation →
Kinematics — all drugs for Kinematics →
Postural; Defect — all drugs for Postural; Defect →

Sponsor

Cairo University

Who can join

Adults 50 to 65, female only, with Mobility Limitation or Muscle Relaxation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A recent study aimed to examine the combined effect of Mulligan and muscle energy techniques on postural changes and shoulder kinematics among women who had undergone breast cancer surgery with axillary dissection.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Efficacy of Muscle Energy and Mulligan Mobilization Techniques for the Upper Extremities and Posture after Breast Cancer Surgery with Axillary Dissection: A Randomized Controlled Trial.
Elabd OM, Etoom M, Jahan AM, Elabd AM, et al · · 2024 · PMID 38398293 · DOI 10.3390/jcm13040980

Verify or expand the search:

Other recruiting trials for Mobility Limitation

Currently open trials in the same condition.

NCT07125378 — Living Independence Through Functional Training · Phase 1, PHASE2 · recruiting
NCT07174973 — Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis · NA · recruiting
NCT07308353 — Comparative Effects Of Exergaming And Otago Exercise On Anticipatory Postural Control And Sensory Integration In Older A · NA · active not recruiting
NCT06686121 — Improving Mobility After Revascularization in Peripheral Artery Disease · Phase 3 · recruiting
NCT06592144 — TESTO-TRIAL: Use of Testosterone in Critically Ill Patients · Phase 4 · active not recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05911867 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 22 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05911867.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing